|
Re: The new competitors: SGLT2 inhibitors and GLP-1 Receptor Agonists
|
3
|
Resverlogix Corp.
|
Jun 14, 2016 11:25AM
|
|
Re: The move in the stock on Friday was disappointing.
|
9
|
Resverlogix Corp.
|
Nov 02, 2019 01:56PM
|
|
Re: The move in the stock on Friday was disappointing.
|
9
|
Resverlogix Corp.
|
Nov 02, 2019 05:29PM
|
|
Re: The MD@A for the period ending July 31, 2017
|
8
|
Resverlogix Corp.
|
Sep 14, 2017 10:18AM
|
|
Re: The MD@A for the period ending July 31, 2017
|
3
|
Resverlogix Corp.
|
Sep 14, 2017 10:39AM
|
|
Re: The MD@A for the period ending July 31, 2017
|
5
|
Resverlogix Corp.
|
Sep 14, 2017 01:53PM
|
|
Re: The MD@A for the period ending July 31, 2017
|
4
|
Resverlogix Corp.
|
Sep 14, 2017 04:47PM
|
|
Re: The MD@A for the period ending July 31, 2017
|
5
|
Resverlogix Corp.
|
Sep 14, 2017 11:34PM
|
|
Re: The MD@A for the period ending July 31, 2017
|
6
|
Resverlogix Corp.
|
Sep 15, 2017 10:08AM
|
|
Re: The Longer It Lasts, The Better It Is???
|
5
|
Resverlogix Corp.
|
Dec 21, 2015 11:05PM
|
|
Re: The Longer It Lasts, The Better It Is???
|
4
|
Resverlogix Corp.
|
Dec 21, 2015 11:47AM
|
|
Re: The Life Sciences Report Interview with George Zavoico (4/6/16)
|
2
|
Resverlogix Corp.
|
Apr 07, 2016 02:12PM
|
|
Re: The last DSMB update of Feb 26th....
|
2
|
Resverlogix Corp.
|
Jun 27, 2018 09:49AM
|
|
Re: The last DSMB update of Feb 26th....
|
4
|
Resverlogix Corp.
|
Jun 25, 2018 11:07AM
|
|
Re: The last DSMB update of Feb 26th....
|
5
|
Resverlogix Corp.
|
Jun 25, 2018 02:45PM
|
|
Re: The last DSMB update of Feb 26th....
|
3
|
Resverlogix Corp.
|
Jun 26, 2018 01:13PM
|
|
Re: The last DSMB update of Feb 26th....
|
6
|
Resverlogix Corp.
|
Jun 26, 2018 07:09PM
|
|
Re: THE KD/EASTERN NR
|
|
Zenith Epigenetics
|
May 16, 2016 10:44PM
|
|
Re: The journey to the finish line
|
3
|
Resverlogix Corp.
|
May 12, 2018 12:36PM
|
|
Re: The journey to the finish line
|
6
|
Resverlogix Corp.
|
May 12, 2018 04:45PM
|
